Asep Medical Holdings Inc
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnosti… Read more
Asep Medical Holdings Inc - Asset Resilience Ratio
Asep Medical Holdings Inc (SEPSF) has an Asset Resilience Ratio of 0.41% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2023)
This chart shows how Asep Medical Holdings Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Asep Medical Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $101.85K | 0.41% |
| Total Liquid Assets | $101.85K | 0.41% |
Asset Resilience Insights
- Limited Liquidity: Asep Medical Holdings Inc maintains only 0.41% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Asep Medical Holdings Inc Industry Peers by Asset Resilience Ratio
Compare Asep Medical Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Asep Medical Holdings Inc (2021–2023)
The table below shows the annual Asset Resilience Ratio data for Asep Medical Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.63% | $160.80K | $25.61 Million | -3.63pp |
| 2022-12-31 | 4.26% | $1.15 Million | $27.08 Million | +2.99pp |
| 2021-12-31 | 1.27% | $390.76K | $30.72 Million | -- |